OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13

Showing 13 citing articles:

The Liver King Lie: Misrepresentation, justification, and public health implications
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23

Anabolics coaching: Emic harm reduction or a public health concern?
Nick Gibbs, Luke Cox, Luke A. Turnock
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100227-100227
Open Access | Times Cited: 35

Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK
Dr Luke Turnock, Nick Gibbs
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100251-100251
Open Access | Times Cited: 20

Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18

The Enhanced Games or Enhancing Harm?
Andrew Richardson
Performance Enhancement & Health (2024) Vol. 12, Iss. 3, pp. 100285-100285
Open Access | Times Cited: 6

Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10

The Enhanced Games: Prohibition, harm reduction & the future of sport
Luke A. Turnock
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100295-100295
Open Access | Times Cited: 3

Semaglutide, Testosterone and Sildenafil advertising on social media: The Normalisation of lifestyle enhancement drugs
Mikey Hirst, Luke A. Turnock
Performance Enhancement & Health (2024), pp. 100303-100303
Open Access | Times Cited: 3

Novel wellbeing and repair peptide use in the UK: Netnographic findings
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2

Further considerations and questions regarding the enhanced games
Andrew Richardson
Performance Enhancement & Health (2024), pp. 100306-100306
Closed Access

The IPEDs assemblage: Tracing the entanglements of biomedicine, technology, enhancement and anti-doping policies in sport and society
Timothy Piatkowski, Luke A. Turnock, Nick Gibbs, et al.
Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine (2024)
Closed Access

Continuing the conversation: Anabolics coaching: Emic harm reduction or a public health concern?
Nick Gibbs, Luke Cox, Dr Luke Turnock
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100234-100234
Closed Access

Page 1

Scroll to top